Core Viewpoint - Zhejiang Tailin Biotechnology Co., Ltd. has recently obtained five patent certificates, which will enhance its intellectual property protection and maintain its technological leadership in the industry [4]. Patent Acquisition Summary - The company’s wholly-owned subsidiary, Zhejiang Tailin Life Science Co., Ltd., has acquired five patents, including one invention patent. The details are as follows: - Patent for gas sterilization resistance detection device and method (Invention) [4] - Appearance patents for two types of plankton pretreatment equipment, a stationary sampler, and a compressed air microbiological testing instrument [4]. - The patents are expected to strengthen the company's innovation mechanism and core competitiveness, although they will not have a significant immediate impact on production and operations [4].

Group 1 - TaiLin Bio (SZ 300813) announced on September 22 that its wholly-owned subsidiary, Zhejiang TaiLin Life Sciences Co., Ltd., has recently obtained 5 patent certificates [1] - The patents include "Gas Sterilization Resistance Detection Device and Method for Zero Rise Period of Gas Concentration" and "Plankton Pretreatment Equipment (1)" [1] - For the fiscal year 2024, TaiLin Bio's revenue composition is projected to be 90.04% from the pharmaceutical industry and 9.96% from other businesses [1] Group 2 - As of the report, TaiLin Bio has a market capitalization of 4.5 billion yuan [1]

南财智讯9月22日电，泰林生物发布公告称，全资子公司泰林生命科学近日收到国家知识产权局颁发的5 项《专利证书》。专利名称分别为"气体浓度零上升期的气体灭菌抗力检测装置及其检测方法"、"浮游 生物预处理设备（1）"、"静置取样器"、"压缩空气微生物检验仪"和"浮游生物预处理设备（2）"。 ...